BioCentury
ARTICLE | Company News

Agennix cancer, dermatology news

April 15, 2013 7:00 AM UTC

At Sept. 30, 2012, Agennix had €5.8 ($7.4 million) in cash and a nine-month net cash burn of €33 million ($42.4 million). Last August, Agennix unveiled details of a restructuring, including headcount ...